Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Roczniki Akademii Medycznej W Bialymstoku (1995)|February 11, 1999
Epidemiology of erythema migrans in north-eastern PolandB Chodynicka, I FlisiakWiadomosci Lekarskie (Warsaw, Poland : 1960)|May 10, 2001
[Antibodies against Borrelia afzelli in patients with an early stage of Lyme disease]I Flisiak, B ChodynickaDermatology and Therapy|June 16, 2023
Kynurenine Pathway in Psoriasis-a Promising Link?A Stepaniuk, A Baran, I FlisiakBiomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 13, 2006
Plasma and scales levels of interleukin 18 in comparison with other possible clinical and laboratory biomarkers of psoriasis activityI Flisiak, A Klepacki, B ChodynickaJournal of the European Academy of Dermatology and Venereology : JEADV|July 1, 2005
Effect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1I Flisiak, H Myśliwiec, B ChodynickaThe Journal of Dermatological Treatment|August 22, 2015
The effect of topical treatment and psoriasis severity on serum retinol-binding protein-4 levelsA Baran, M Swiderska, I FlisiakJournal of Medicine|February 23, 2007
Clinical features and specific immunological response to Borrelia afzelii in patients with acrodermatitis chronica atrophicansI Flisiak, R A Schwartz, B ChodynickaThe Journal of Dermatological Treatment|May 12, 2016
Effect of psoriasis activity and topical treatment on serum lipocalin-2 levelsA Baran, M Świderska, H Myśliwiec, et al.Przeglad Epidemiologiczny|January 1, 1997
[Late consequences of untreated lyme borreliosis]B Chodynicka, I Flisiak, C Lukaszuk, et al.The Journal of Dermatological Treatment|April 24, 2014
Serum adiponectin and leptin levels in psoriatic patients according to topical treatmentA Baran, I Flisiak, J Jaroszewicz, et al.Pageof 2